BGE-102 Data Inspires Confidence for BioAge Labs (BIOA)

On March 10, Citi maintained a Buy standing connected BioAge Labs Inc. (NASDAQ:BIOA). The steadfast importantly accrued its terms people from $15 to $52, citing a compelling outlook arsenic the institution approaches proof-of-concept information for BGE-102.

Tonhom1009/Shutterstock.com

Citi besides sees important commercialized imaginable for the therapy crossed aggregate indications, including highest U.S. income of $9.5B for atherosclerotic cardiovascular illness and $2B for diabetic macular edema, supporting a much optimistic presumption of the company’s semipermanent maturation trajectory.

On February 25, Oppenheimer began sum of BioAge Labs Inc. (NASDAQ:BIOA) with a $60 terms people and an Outperform rating. The steadfast is rather affirmative astir the company’s pb compound, BGE-102, which tin inhibit the NLRP3 pathway. This has precocious received a batch of attraction owed to the imaginable of the compound successful the simplification of cardiovascular risk, particularly aft the affirmative Phase 2 results from Ventyx Biosciences.

Oppenheimer points retired the captious differentiation of the company’s compound successful examination to different adjacent NLRP3 and Interleukin compounds.

BioAge Labs Inc. (NASDAQ:BIOA) is engaged successful processing therapeutic merchandise candidates for metabolic diseases. Its merchandise portfolio includes an NLRP3 inhibitor successful Phase 1 of objective proceedings and BGE-102. It is besides moving connected APJ agonists for obesity.

While we admit the imaginable of BIOA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.